Systemic meglumine antimoniate in acute cutaneous leishmaniasis: children versus adults (Q34707772)

4 August 2017

Systemic meglumine antimoniate in acute cutaneous leishmaniasis: children versus adults (English)

1 reference

4 August 2017

cutaneous leishmaniasis

1 reference

inferred from title

meglumine antimoniate

1 reference

Pouran Layegh

1

1 reference

4 August 2017

Sara Rahsepar

series ordinal

2

1 reference

4 August 2017

Amir Ali Rahsepar

series ordinal

3

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 April 2011

1 reference

4 August 2017

4

1 reference

American Journal of Tropical Medicine and Hygiene

inferred from page(s)

published in

1 reference

4 August 2017

84

1 reference

4 August 2017

4

1 reference

4 August 2017

539-542

1 reference

Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: a randomized assessor-blind controlled trial

4 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062445

Childhood cutaneous leishmaniasis: report of 117 cases from Iran

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062445

Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062445

Management of cutaneous leishmaniasis in adults and children

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062445

Developmental pharmacology--drug disposition, action, and therapy in infants and children

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062445

An overview of paediatric leishmaniasis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062445

Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonate for cutaneous leishmaniasis due to Leishmania viannia species

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062445

Cutaneous leishmaniasis in primary school children in the south-eastern Iranian city of Bam, 1994-95.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062445

Efficacy of cryotherapy versus intralesional meglumine antimoniate (glucantime) for treatment of cutaneous leishmaniasis in children.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062445

Evaluation of PCR assay in diagnosis and identification of cutaneous leishmaniasis: a comparison with the parasitological methods.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062445

Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062445

Evaluating the efficacy of allopurinol and meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062445

Cryotherapy as an adjunct to systemic antimonials for cutaneous leishmaniasis in children

26 October 2018

1 reference

12 December 2020

Pharmacokinetics of antimony in children treated for leishmaniasis with meglumine antimoniate

1 reference

12 December 2020

Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate

1 reference

12 December 2020

Cutaneous leishmaniasis: schedules for intralesional treatment with sodium stibogluconate

1 reference

12 December 2020

10.4269/AJTMH.2011.10-0002

Identifiers

DOI

1 reference

4 August 2017

1 reference

4 August 2017

1 reference